AGT and triple-A syndrome: To assess the therapeutic impact of degrading extracellular nucleic acids on AAA progression in the AngII model, we allowed aneurysms to develop until day 8, then mice were stratified into treatment and control groups based on 1:1 matching of aortic volume growth (see experimental schematic in Fig. 2A).